PharmGen Science Inc (004720) — Net Asset Quality Index
PharmGen Science Inc (004720) has a Net Asset Quality Index of 74.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩331.46 Billion minus total liabilities of ₩83.70 Billion yields net assets of ₩247.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 004720 total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
PharmGen Science Inc Net Asset Quality Index Over Time (2004–2024)
This chart shows how PharmGen Science Inc's Net Asset Quality Index has evolved across 17 annual periods from 2004 to 2024. As of September 2025, the index stands at 74.7%, representing net assets of ₩247.76 Billion against total assets of ₩331.46 Billion KRW. For live market cap and overall valuation, see PharmGen Science Inc (004720) market capitalisation.
Annual Net Asset Quality Index for PharmGen Science Inc (2004–2024)
The table below presents the year-by-year Net Asset Quality Index for PharmGen Science Inc from 2004 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 004720 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.6% | ₩249.43 Billion | ₩363.45 Billion | ₩114.02 Billion | ▲ +0.7 pp |
| 2023 | 67.9% | ₩228.21 Billion | ₩335.92 Billion | ₩107.71 Billion | ▲ +2.7 pp |
| 2022 | 65.3% | ₩207.12 Billion | ₩317.39 Billion | ₩110.28 Billion | ▲ +7.6 pp |
| 2021 | 57.6% | ₩126.93 Billion | ₩220.32 Billion | ₩93.39 Billion | ▼ -4.0 pp |
| 2020 | 61.7% | ₩83.57 Billion | ₩135.54 Billion | ₩51.97 Billion | ▲ +5.4 pp |
| 2019 | 56.2% | ₩56.25 Billion | ₩100.03 Billion | ₩43.79 Billion | ▼ -1.7 pp |
| 2018 | 57.9% | ₩56.85 Billion | ₩98.19 Billion | ₩41.35 Billion | ▼ -16.7 pp |
| 2017 | 74.6% | ₩51.05 Billion | ₩68.48 Billion | ₩17.43 Billion | ▲ +17.9 pp |
| 2016 | 56.6% | ₩36.41 Billion | ₩64.30 Billion | ₩27.89 Billion | ▼ -5.1 pp |
| 2015 | 61.7% | ₩28.66 Billion | ₩46.45 Billion | ₩17.79 Billion | ▲ +13.9 pp |
| 2014 | 47.8% | ₩20.12 Billion | ₩42.04 Billion | ₩21.93 Billion | ▼ -12.8 pp |
| 2013 | 60.6% | ₩23.83 Billion | ₩39.33 Billion | ₩15.49 Billion | ▼ -0.2 pp |
| 2012 | 60.8% | ₩25.90 Billion | ₩42.61 Billion | ₩16.71 Billion | ▲ +17.1 pp |
| 2011 | 43.6% | ₩18.69 Billion | ₩42.82 Billion | ₩24.13 Billion | ▼ -6.1 pp |
| 2005 | 49.8% | ₩33.07 Billion | ₩66.47 Billion | ₩33.40 Billion | ▼ -0.6 pp |
| 2004 | 50.3% | ₩24.91 Billion | ₩49.49 Billion | ₩24.58 Billion | ▼ -1.2 pp |
| 2004 | 51.6% | ₩25.73 Billion | ₩49.90 Billion | ₩24.17 Billion | — |